KARD · Kardigan Inc. Common Stock
View on chartInsiders & Stakes
| Paul L. Berns | ▲ Buy | Open Market | 15,042,035 Shares held | 6/22/2026 | View profile |
| ARCH Venture Partners XIII, LLC | ▲ Buy | Open Market | 15,042,035 Shares held | 6/22/2026 | View profile |
| HRTG GPE, LLC | ▲ Buy | Open Market | 14,866,868 Shares held | 6/22/2026 | View profile |
| GIANAKAKOS ANASTASIOS President & CEO | ▼ Sell | Other | 498,692 Shares held | 6/17/2026 | View profile |
| Edelberg Jay Chief Medical Officer | ▲ Buy | Grant | 183,327 Shares held | 6/17/2026 | View profile |
| Pasternak Andy Chief Strategy Officer | ▲ Buy | Grant | 79,640 Shares held | 6/17/2026 | View profile |
| Jahn Brianne Chief Financial Officer | ▲ Buy | Grant | 79,640 Shares held | 6/17/2026 | View profile |
| Moriarty John B Chief Legal Officer | ▲ Buy | Grant | 47,784 Shares held | 6/17/2026 | View profile |
| PERCEPTIVE ADVISORS LLC Director | ▲ Buy | Grant | 20,706 Shares held | 6/17/2026 | View profile |
| Timothy P. Walbert Director | ▲ Buy | Grant | 20,706 Shares held | 6/17/2026 | View profile |
| David P. Meeker President and CEO | ▲ Buy | Grant | 20,706 Shares held | 6/17/2026 | View profile |
| Popovits Kimberly J Director | ▲ Buy | Grant | 20,706 Shares held | 6/17/2026 | View profile |
| Giordano Douglas E. | ▲ Buy | Grant | 20,706 Shares held | 6/17/2026 | View profile |
Transaction History
| HRTG GPE, LLC | ▲ Buy | Open Market | 3,125,000 | $50.0M | 6/22/2026 |
| Paul L. Berns | ▲ Buy | Open Market | 1,250,000 | $20.0M | 6/22/2026 |
| ARCH Venture Partners XIII, LLC | ▲ Buy | Open Market | 1,250,000 | $20.0M | 6/22/2026 |
| Giordano Douglas E. | ▲ Buy | Grant | 20,706 | $0 | 6/17/2026 |
| PERCEPTIVE ADVISORS LLC | ▲ Buy | Grant | 20,706 | $0 | 6/17/2026 |
| HRTG GPE, LLC | ▼ Sell | Other | 6,150,502 | — | 6/17/2026 |
| HRTG GPE, LLC | ▼ Sell | Other | 3,242,993 | — | 6/17/2026 |
| Moriarty John B | ▲ Buy | Grant | 47,784 | $0 | 6/17/2026 |
| Jahn Brianne | ▲ Buy | Grant | 79,640 | $0 | 6/17/2026 |
| Popovits Kimberly J | ▲ Buy | Grant | 20,706 | $0 | 6/17/2026 |
| Timothy P. Walbert | ▲ Buy | Grant | 20,706 | $0 | 6/17/2026 |
| GIANAKAKOS ANASTASIOS | ▼ Sell | Other | 28,702 | — | 6/17/2026 |
| GIANAKAKOS ANASTASIOS | ▼ Sell | Other | 41,001 | — | 6/17/2026 |
| GIANAKAKOS ANASTASIOS | ▼ Sell | Other | 498,692 | — | 6/17/2026 |
| Edelberg Jay | ▲ Buy | Grant | 47,784 | $0 | 6/17/2026 |
| HRTG GPE, LLC | ▼ Sell | Other | 2,050,166 | — | 6/17/2026 |
| HRTG GPE, LLC | ▼ Sell | Other | 2,348,373 | — | 6/17/2026 |
| Pasternak Andy | ▲ Buy | Grant | 79,640 | $0 | 6/17/2026 |
| David P. Meeker | ▲ Buy | Grant | 20,706 | $0 | 6/17/2026 |
| Paul L. Berns | ▼ Sell | Other | 13,792,035 | — | 6/17/2026 |
| Paul L. Berns | ▲ Buy | Grant | 20,706 | $0 | 6/17/2026 |
| Edelberg Jay | ▼ Sell | Other | 97,587 | — | 6/17/2026 |
| ARCH Venture Partners XIII, LLC | ▼ Sell | Other | 13,792,035 | — | 6/17/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
UBS initiates coverage on Kardigan with $25 price target
UBS has started tracking Kardigan Inc. and set a price target of $25. This new analyst view is notable because it sits below the current average analyst target of $42.25. The stock is currently trading near its support level, which may reflect the mixed sentiment from this new coverage.
UBS initiates coverage on Kardigan with $25 price target. UBS has started tracking Kardigan Inc. and set a price target of $25. This new analyst view is notable because it sits below the current average analyst target of $42.25. The stock is currently trading near its support level, which may reflect the mixed sentiment from this new coverage.